FULL NAME
*
BADGE # / Reference No. / Confirmation No.
*
TOPICS / SPEAKER
MS Biomarkers
:
Dr Abubaker Al Madani
*
1-Poor
2-Average
3-Good
4-Excellent
Speaker
Content
Audio Visual
Discussion
Impact on Patient Care
Neuro-imaging of NMOSD-
MRI Update
:
Dr Manzoor Ahmed
*
1-Poor
2-Average
3-Good
4-Excellent
Speaker
Content
Audio Visual
Discussion
Impact on Patient Care
Getting Closer to Life
without MS
:
Dr Mona Thakre and Dr. Jihad Said Salim Inshasi
*
1-Poor
2-Average
3-Good
4-Excellent
Speaker
Content
Audio Visual
Discussion
Impact on Patient Care
Platform Therapy: Are They Still Alive?
:
Dr Taoufik Alsaadi
*
1-Poor
2-Average
3-Good
4-Excellent
Speaker
Content
Audio Visual
Discussion
Impact on Patient Care
Updates in MS B-Cell Therapies
:
Dr Derk W. Krieger
*
1-Poor
2-Average
3-Good
4-Excellent
Speaker
Content
Audio Visual
Discussion
Impact on Patient Care
High-Efficacy DMTs
:
Dr Beatrice Benedetti
*
1-Poor
2-Average
3-Good
4-Excellent
Speaker
Content
Audio Visual
Discussion
Impact on Patient Care
NMOSD : The New Era
:
Dr Mustafa Shakra
*
1-Poor
2-Average
3-Good
4-Excellent
Speaker
Content
Audio Visual
Discussion
Impact on Patient Care
The Use of Alemtuzumab in Patients with Relapsing-remitting Multiple Sclerosis: The Gulf Perspective
:
Dr Raed Alroughani
*
1-Poor
2-Average
3-Good
4-Excellent
Speaker
Content
Audio Visual
Discussion
Impact on Patient Care
When Patient with Multiple Sclerosis Gets Old
:
Dr Aref Al Shehi
*
1-Poor
2-Average
3-Good
4-Excellent
Speaker
Content
Audio Visual
Discussion
Impact on Patient Care
Why Timing is Crucial with Ocrelizumab
:
Dr Deeb Kayed
*
1-Poor
2-Average
3-Good
4-Excellent
Speaker
Content
Audio Visual
Discussion
Impact on Patient Care
Primary Progressive MS : The Mimics
:
Dr Areen Said
*
1-Poor
2-Average
3-Good
4-Excellent
Speaker
Content
Audio Visual
Discussion
Impact on Patient Care
Women and MS
:
Dr Victoria Ann Mifsud
*
1-Poor
2-Average
3-Good
4-Excellent
Speaker
Content
Audio Visual
Discussion
Impact on Patient Care
Natalizumab, The Power You Need the Experience You Trust for Your Highly Active Relapsing-Remitting Multiple Sclerosis (RRMS) Patients
:
Dr Derk W. Krieger
*
1-Poor
2-Average
3-Good
4-Excellent
Speaker
Content
Audio Visual
Discussion
Impact on Patient Care
The Clinical Value of Glatiramer Acetate
:
Dr Ahmed Shatila
*
1-Poor
2-Average
3-Good
4-Excellent
Speaker
Content
Audio Visual
Discussion
Impact on Patient Care
Stem Cell Transplantation in MS
:
Dr Ruqqia Mir
*
1-Poor
2-Average
3-Good
4-Excellent
Speaker
Content
Audio Visual
Discussion
Impact on Patient Care
RIS
:
Dr Suzan Ibrahim Noori
*
1-Poor
2-Average
3-Good
4-Excellent
Speaker
Content
Audio Visual
Discussion
Impact on Patient Care
Which platform do you prefer: Zoom or Hubilo virtual platform? Why?
*
This Represented New Knowledge:
*
None
Some
Moderate
All New
The Program
*
Yes
No
The program's objectives were clearly defined.
The program met the started objectives.
The program was relevant to the topic.
The program met my expectations.
There was suffiecient time for discussion.
The program was well organized.
Should this program be offered again, if YES
How Often ?
*
Annually
Biannually
Other
Kindly suggest any modifications that we can bring to our CME Programs.?
*
What topics would you like to see us present in the future.?
*
PLEASE CLICK ON THE DONE BUTTON TO RETRIEVE YOUR CERTIFICATE
